Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
79
days
The emerging clinical landscape of circulating tumor DNA in bladder cancer and renal cell carcinoma from tumor-specific biology to detection strategies and translational hurdles
AuthorsWenxiang Lin; Maoyuan Shi; Shehaitong Jiang; Lebin Luo
Affiliations1. Department of Urology, Luzhou People’s Hospital, Luzhou, China
97
days
m 6 A-modified circFADS2 promotes hepatocellular carcinoma progression through CAPRIN1-mediated TYMS mRNA stability
AuthorsHao Jiang; Weixia Xie; Yixin Cui; Yuanting Ye
Affiliations1. Department of Infectious Diseases, The Affiliated People’s Hospital of Ningbo University, Ningbo, P. R. China; 2. Ningbo Key Laboratory of Precision Integrated Prevention and Treatment of Comorbidities in Steatotic Liver Disease, Ningbo, P. R. China; 3. Operating Room, The Affiliated People’s Hospital of Ningbo University, Ningbo, P. R. China
121
days
Synchronous carcinoma of the anal canal and stomach presenting as severe anemia: a case report
AuthorsManoj Narayan Pragasam; Karikal Chakaravarthi; Naganath Babu Obla Lakshmanamoorthy; Keerthana Sivakumar; Ganapathy Shivasekar
Affiliations1. SRM Medical College Hospital and Research Centre, Faculty of medicine and health sciences, SRM institute of science and Technology, Kattankulathur, India; 2. Department of Surgical Gastroenterology SRM Medical College Hospital and Research Centre, Faculty of medicine and health sciences, SRM institute of science and Technology, Kattankulathur, India; 3. Department of Pathology SRM Medical College Hospital and Research Centre, Faculty of medicine and health sciences, SRM institute of science and Technology, Kattankulathur, India
320
days
Differential expression analysis of miRNAs and identification of potential key genes in pediatric T-cell acute lymphoblastic leukemia
AuthorsAaradhana Joshi; Parminder Kaur; Sargeet Kaur; Prateek Bhatia; Amita Trehan; Sreejesh Sreedharanunni; Minu Singh
Affiliations1. Hematology Oncology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India; 2. Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
124
days
The deubiquitinating enzyme regulatory network in malignant progression of breast cancer encompasses mechanisms of action, clinical significance and emerging therapeutic targets
AuthorsXiaoyu Zhang; Dunya Yang; Xiangwu Lin; Zhirong Yang; Yun Lin; Juan Yao; Lingdan Chen; Xi Chen; Shiyu Liu; Qunxiang Chen
Affiliations1. Department of Oncology, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China; 2. Department of Oncology, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, China
97
days
LncRNA DLGAP1-AS2 promotes ESCC progression and indicates unfavorable prognosis via the miR-101-3p/EZH2 axis
AuthorsLiwei Tang; Yichuan Zhang; Xiangting Cheng
Affiliations1. Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China; 2. Minimally Invasive Endoscopy Center, Digestive Disease Center, The Affiliated Hospital of Panzhihua University, Panzhihua, China; 3. Department of Gastrointestinal Surgery, Zibo Central Hospital, Zibo, China
67
days
pH responsive nanoplatforms for radiosensitization and radioprotection in cancer therapy
AuthorsEnhui Dai; Yiqin Qiu; Huan Xu; Guoqiang Zhong; Wei Feng
Affiliations1. The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China; 2. Zhejiang Cancer Hospital, Hangzhou, China; 3. College of Clinical Medicine, Hebei University of Engineering, Handan, China; 4. Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China; 5. Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China
215
days
Integrative transcriptomic analysis identifies shared coding and non-coding biomarkers in tongue squamous cell carcinoma across diverse populations
AuthorsRonit Roy; Monika Rajput; Manoj Pandey
Affiliations1. DHR-ICMR Advanced Molecular Oncology Diagnostic Services (DIAMOnDS), Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; 2. Devi Ahilya Vishwavidyalaya, Indore, India; 3. Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
74
days
Epidemiological risk factors and inferred p53 pathway dysregulation in Esophageal squamous cell carcinoma in the Somali population
AuthorsHashim Mohamed Rooraye; Yusuf Lukman; Rapeah Suppian; Akbar Ali; Che Ismail Che Lah; Ramiza Ramza Ramli
Affiliations1. School of Health Sciences, (Health Campus), Universiti Sains Malaysia,16150, Kubang Kerian, Malaysia; 2. Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia (Health Campus), Kubang Kerian, Malaysia; 3. Department of Medical Laboratory Sciences, Kebbi State College of Health Sciences and Technology, Jega, Nigeria; 4. Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia (Health Campus), Kubang Kerian, Malaysia; 5. Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia; 6. Department of Otorhinolaryngology–Head and Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia
133
days
AKR7A3 rs1738023 association with susceptibility to female hepatocellular carcinoma and its role in AFB1 metabolism and tumor
AuthorsJiakao Zhang; Yuan Liao; Ketuan Huang; Yongfei He; Meifeng Chen; Shutian Mo; Qiang Gao; Xinping Ye; Tao Peng; Chuangye Han
Affiliations1. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China; 2. Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning, People’s Republic of China; 3. Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Nanning, People’s Republic of China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days